Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: The effect on Cisplatin - DNA adducts

Chemical Research in Toxicology

Volumn 24, Issue 6, 2011, Pages 896-904

  García Sar, Daniel ^a   Montes Bayón, Maria ^a   Blanco González, Elisa ^a   Sierra Zapico, Luisa M ^a   Sanz Medel, Alfredo ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CREATININE; DNA; DRINKING WATER; SELENOMETHIONINE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; ISOTOPE DILUTION ASSAY; KIDNEY PARENCHYMA; LIVER; MALE; NEPHROTOXICITY; NONHUMAN; RAT; RENAL PROTECTION; URINARY EXCRETION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BODY WEIGHT; CISPLATIN; CREATININE; DNA ADDUCTS; DRUG INTERACTIONS; KIDNEY; KIDNEY DISEASES; LIVER; MALE; MODELS, MOLECULAR; PLATINUM; RATS; RATS, WISTAR; SELENIUM; SELENOMETHIONINE;

ANIMALIA; RATTUS;

EID: 79959445798     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx200085n     Document Type: Article

References (37)

1. Lebwohl, D. and Canetta, R. (1998) Clinical development of platinum complexes in cancer therapy: An historical perspective and an update Eur. J. Cancer 34, 1522-1534 (Pubitemid 28446332)
2. Rosenberg, B. (1985) Fundamental studies with cisplatin Cancer 55, 2303-2315
3. Boulikas, T. and Vougiouka, M. (2003) Cisplatin and platinum drugs at the molecular level Oncol. Rep. 10, 1663-1682
4. Jordana, P. and Carmo-Fonsecab, M. (2000) Molecular mechanisms involved in cisplatin cytotoxicity Cell. Mol. Life Sci. 57, 1229-1235
5. Lieberthal, W., Triaca, V., and Levine, J. (1996) Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis Am. J. Physiol.-Renal Phys. 270, F700-F708
6. Xin, Y., Panichpisal, K., Kurtzman, N., and Nugent, K. (2007) Cisplatin Nephrotoxicity: A Review Am. J. Med. Sci. 334, 115-124 (Pubitemid 47262919)
7. Antunes, G., Darin, J. D., and Bianchi, M. de L. P. (2001) Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats Pharmacol. Res. 43, 145-150 (Pubitemid 32601443)
8. Antunes, G., Darin, J. D., and Bianchi, M. de L. P. (2000) Protective effects of Vitamin C against cisplatin-induced nephtotoxicity and lipid peroxidation in adult rats Pharmacol. Res. 41, 405-411
9. Weijl, N. I., Elsendoorn, T. J., Lentjes, E. G. W. M., Hopman, G. D., Wipkink-Bakker, A., Zwinderman, A. H., Cleton, F. J., and Osanto, S. (2004) Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: A randomised, double-blind, placebo-controlled study Eur. J. Cancer 40, 1713-1723 (Pubitemid 38902907)
10. Chirino, Y. I. and Pedraza-Chaverri, J. (2009) Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity Exp. Toxicol. Pathol. 61, 223-242
11. Matsushima, H., Yonemura, K., Ohishi, K., and Hishida, A. (1998) The role of oxygen free radicals in cisplatin-induced acute renal failure in rats J. Lab. Clin. Med. 131, 518-526 (Pubitemid 28278570)
12. Pratibha, R., Sameer, R., Rataboli, P. V., Bhiwgade, D. A., and Dhume, C. Y. (2006) Enzymatic studies of cisplatin induced oxidative stress in hepatic tissue of rats Eur. J. Pharmacol. 532, 290-293
13. Masuda, H., Tanaka, T., and Takahama, U. (1994) Cisplatin generates superoxide anion by interaction with DNA in a cell-free system Biochem. Biophys. Res. Commun. 203, 1175-1180 (Pubitemid 24304953)
14. Sadzuka, Y., Shoji, T., and Takino, Y. (1992) Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation Biochem. Pharmacol. 43, 1873-1875
15. Kasherman, Y., Sturup, S., and Gibson, D. (2009) Is Glutathione the Major Cellular Target of Cisplatin? A Study of the Interactions of Cisplatin with Cancer Cell Extracts J. Med. Chem. 52, 4319-4328
16. Weijl, N. I., Hopman, G. D., Wipkink-Bakker, A., Lentjes, E. G. W. M., Berger, H. M., Cleton, F. J., and Osanto, S. (1998) Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients Ann. Oncol. 9, 1331-1337 (Pubitemid 29045573)
17. Martinis, B. S. and Bianchi, M. de P. (2001) Effect of Vitamin C supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats Pharmacol. Res. 44, 317-320 (Pubitemid 32977924)
18. de Oliveira Mora, L., Greggi Antunes, L., Colleta Fracescato, H. D., and Pires Bianchi, M. L. (2003) The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats Pharmacol. Res. 47, 517-522
19. Atessahin, A., Yilmaz, S., Karahana, I., Ceribasic, O. A., and Karaoglu, A. (2005) Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats Toxicology 212, 116-123 (Pubitemid 40981968)
20. Legendre, F., Bas, V., and Kozelka, J. (2000) A complete kinetic study of GG versus AG platination suggests that the doubly aquated derivatives of cisplatin are the actual DNA binding species Chem.-Eur. J. 6, 2002-2010
21. Gupta, R., Beek, J. L., and Sheil, M. M. (2005) Identification of bifunctional GA and AG intrastrand crosslinks formed between cisplatin and DNA J. Inorg. Biochem. 99, 552-559 (Pubitemid 40044747)
22. Jamieson, E. R. and Lippard, S. J. (1999) Structure, recognition, and processing of cisplatin-DNA adducts Chem. Rev. 99, 2467-2498
23. Ip, C. (1998) Lessons from basic research in selenium and cancer prevention J. Nutr. 128, 1845-1854 (Pubitemid 28509845)
24. Clark, L. C., Combs, G. F., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Park, H. K., Sanders, B. B., Smith, C. L., and Taylor, J. R. (1996) Effects of Se supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial J. Am. Med. Assoc. 276, 1957-1963 (Pubitemid 26427723)
25. Yan, L., Yee, J. A., Li, D., McGuire, M., and Graef, G. L. (1999) Dietary supplementation of selenomethionine reduces metastasis of melanoma cells in mice Anticancer Res. 19, 1337-1342 (Pubitemid 29257579)
26. Hu, Y. J., Chen, Y., Zhang, Y. Q., Zhou, M. Z., Song, X. M., Zhang, B. Z., Luo, L., Xu, P. M., Zhao, Y. N., Zhao, Y. B., and Cheng, G. (1997) The protective role of selenium on the toxicity of cisplatin-contained chemotherapy regimen in cancer patients Biol. Trace Elem. Res. 56, 331-341 (Pubitemid 27255781)
27. Colleta Francescato, H. D., Silva Costa, R., Rodrigues Camargo, S. M., Zanetti, M. A., Lavrador, M. A., and Pires Bianchi, M. L. (2001) Effect of oral selenium administration on cisplatin-induced nephrotoxicity in rats Pharmacol. Res. 43, 77-82 (Pubitemid 32577758)
28. Satoh, M., Naganuma, A., and Imura, N. (1992) Effect of co-administration of selenite on the toxicity and antitumor activity of cisdiamminedichloroplatinum (II) given repeatedly to mice Cancer Chemother. Pharmacol. 30, 439-443
29. Eric, D. L., Rende, G., Carol, P., and Kil, J. (2005) Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen Hear. Res. 201, 81-89 (Pubitemid 40255547)
30. Rao, M. and Rao, M. N. A. (1998) Protective effects of selenomethionine against cisplatin-induced renal toxicity in mice and rats J. Pharm. Pharmacol. 50, 687-691 (Pubitemid 28297236)
31. Rao, M., Kamath, R., and Rao, M. N. A. (1998) Protective effect of selenomethionine against cisplatin-induced nephrotoxicity in C57BL/6J mice bearing B16F1 melanoma without reducing antitumour activity Pharm. Pharmacol. Commun. 4, 549-552 (Pubitemid 28546586)
32. Zhang, J., Peng, D., Lu, H., and Liu, Q. (2008) Attenuating the toxicity of cisplatin by using selenosulfate with reduced risk of selenium toxicity as compared with selenite Toxicol. Appl. Pharmacol. 226, 251-259 (Pubitemid 351172408)
33. Baldew, G., Mol, J. G. J., de Kanter, F. J. J., Van Baar, B., de Goeij, J. J. M., and Vermeulen, N. P. E. (1991) The mechanism of interaction between cisplatin and selenite Biochem. Pharmacol. 41, 1429-1437
34. Sar, D. G., Montes-Bayón, M., Blanco-Gonzalez, E., Sierra, L. M., Aguado, L., Comendador, M. A., Koellensperger, G., Hann, S., and Sanz-Medel, A. (2009) Quantitative profiling of in vivo generated cisplatin-DNA adducts using different isotope dilution strategies Anal. Chem. 81, 9553-9560
35. Liu, Q., Zhang, J., Ke, X., Mei, Y., Zhua, L., and Guo, Z. (2001) ESMS and NMR investigations on the interaction of the anticancer drug cisplatin and chemopreventive agent selenomethionine J. Chem. Soc., Dalton Trans. 911-916
36. Sar, D. G., Montes-Bayón, M., Blanco-González, E., and Sanz-Medel, A. (2006) Speciation studies of cisplatin adducts with DNA nucleotides via elemental specific detection (P and Pt) using liquid chromatography-inductively coupled plasma-mass spectrometry and structural characterization by electrospray mass spectrometry J. Anal. At. Spectrom. 21, 861-868 (Pubitemid 44286291)
37. Portilla, D., Li, S., Nagothu, K. K., Megyesi, J., Kaissling, B., Schnackenberg, L., Safirstein, R. L., and Beger, R. D. (2006) Metabolomic study of cisplatin-induced nephrotoxicity Kidney Int. 69, 2194-2204 (Pubitemid 43882106)